EPO906 Therapy in Patients With Advanced Melanoma
NCT00035165
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
epothilone b
Sponsor
Novartis Pharmaceuticals